153
Participants
Start Date
September 30, 2007
Primary Completion Date
August 31, 2009
Study Completion Date
October 31, 2009
RP101
190 mg oral tablet
Gemcitabine (1000 mg/m2)
30 minute intravenous infusion
St. Luke's Cancer Center, Bethlehem
Integrated Community Oncology Network, LLC, Jacksonville
Lakeland Regional Cancer Center, Lakeland
Gabrail Cancer Center, Canton
Signal Point Clinical Research Center, LLC, Middletown
Medical College of Wisconsin, Froedtert Multi-Disciplinary Cancer Center, Milwaukee
Mid Dakota Clinic, Bismarck
Baylor College of Medicine, Houston
South Texas Oncology and Hematology, PA, San Antonio
Utah Cancer Specialists, Salt Lake City
University of Arizona Medical Center, Arizona Cancer Center, Tucson
Tower Research Foundation at Tower Oncology, Beverly Hills
University of California at San Francisco, San Francisco
Providence Portland Medical Center, Portland
Cancer Care Northwest, Spokane
University of Washington, Seattle
Hospital Italiano Regional del Sur, Bahía Blanca
Hospital Británico de Buenos Aires, Ciudad Autónoma de Buenos Aires
Hospital Zonal General de Agudos San Roque, La Plata
Hospital de Caridade de Ijuí, Ijuí
Hospital de Clínicas de Porto Alegre, Serviço de Oncologia, Porto Alegre
Instituto Nacional do Câncer, Rio de Janeiro
Núcleo de Oncologia da Bahia, Salvador
Hospital do Câncer-AC Camargo, São Paulo
Fundación Arturo López Pérez, Santiago
Hospital Militar, Santiago
Hôpital Gabriel Montpied, Clermont-Ferrand
Centre Hospitalier Départemental, La Roche-sur-Yon
Centre Eugene Marquis, Service d'Oncologie Medicale, Rennes
Universitätsklinikum Dresden, Med. Klinik I, Dresden
Klinikum Region Hannover GmbH, Krankenhause Siloah, Hanover
Klinikum rechts der Isar, Technische Universität München, München
Petz Aladár Megyei Oktató Kórház Orvostovábbképzo Egyetem Oktató-Továbbképzo Kórháza, Onkoradiológia, Gyor
Fovárosi Önkormányzat Egyesített Szent István és Szent László Kórház-Rendelointézet, Budapest
Fovárosi Önkormányzat Uzsoki utcai Kórháza, Budapest
Debreceni Egyetem Orvos és Egészségtudományi Centrum, Onkológiai Tanszék, Debrecen
Maaslandziekenhuis, Sittard
Hospital Nacional Guillermo Almenara Irigoyen, La Victoria
Hospital Nacional Edgardo Rebagliati Martins, Lima
Instituto Oncocenter, San Borja
Samodzielny Publiczny Zaklad Opieki Zdrowotnej Szpital Wojewódzki, Jelenia Góra
I Katedra Chirurgii Ogólnej i Klinika Chirurgii Gastroenterologicznej, Krakow
Wojewódzki Szpital Specjalistyczny im Kopernika w Lodzi, Lódz
Centrum Medyczne MRUKMED, Rzeszów
Institutul Clinic Fundeni, Bucharest
Institutul Oncologic 'Prof. Dr. A. Trestioreanu', Bucharest
Spitalul Clinic de Urgenta Floreasca, Bucharest
Spitalul Clinic Universitar de Urgenta, Bucharest
Hospital Universitario Arnau de Vilanova, Servicio de Oncologia, Lleida
Centro Integral Oncológico Clara Campal, Hospital de Madrid Norte-San Chinarro, Madrid
Hospital 12 de Octubre, Oncology Service, Hospital Materno Infantil, Madrid
Instituto Valenciano de Oncología, Valencia
Hospital Universitario Miguel Servet, Zaragoza
Leicester Royal Infirmary, University Hospitals of Leicester NHS Trust, Leicester
Mount Vernon Hospital, Middlesex
Lead Sponsor
SciClone Pharmaceuticals
INDUSTRY